We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
Advice for medical professionals to follow when assessing drivers with psychiatric disorders.
Explains how commissioners and health professionals can use data and analysis for decisions about neurology services and interventions.
Projects granted during 2014 that have a primary purpose of translational and applied research: human nervous and mental disorders.
Guidance for commissioners and health professionals to make decisions about mental health services and interventions based on data and analysis.
Projects granted during 2016 that have a primary purpose of translational applied research - human nervous and mental disorders.
We’re responsible for handling applications for the discharge of patients detained in psychiatric hospitals. We also handle applications to change community treatment orders and the conditions placed on a ‘conditional discharge’ from hospital. Who we are We are part of...
Advice for medical professionals to follow when assessing drivers with neurological disorders.
A series of reports assessing variation in the premature mortality and excess premature mortality for adults with severe mental illness (SMI).
A framework of modifiable factors to guide promotion of good mental health in babies, children and young people.
Describes a system to track prescribing of antipsychotics, antidepressants and other psychotropics for people with learning disabilities, autism or both.
Volume 50 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Foresight project looking at how future scientific advances may affect our understanding of addiction and drug use.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).